Improving Uptake of Bowel Cancer Screening Among South Asian Adults in Bradford
1 other identifier
interventional
2,300
1 country
1
Brief Summary
Bowel cancer is the second most common cause of cancer related deaths in England. Bowel cancer screening can reduce bowel cancer deaths by detecting bowel cancer early. Previous research has shown that screening can lower a person's risk of dying from bowel cancer by over 25%. In England, the NHS offers free bowel cancer screening for adults aged 60 - 74 years who are registered with a GP every two years, but screening uptake remains poor among those in deprived areas and amongst minority ethnic groups. In socioeconomically deprived areas like Bradford, where there is a high proportion of South Asian residents, bowel cancer screening uptake is low compared to other parts of England. The investigators previous research has shown that people of South Asian ethnicity are limited by many factors beyond language barriers and thus require culturally tailored approaches to facilitate uptake. For this study, the investigators will aim to answer the question: 'Does a culturally tailored enhanced screening kit, comprising an instruction letter and booklet, and a bio-degradable poo catcher increase bowel cancer screening uptake among South Asians living in Bradford?'. Over a 6-month period, individuals registered in 17 GP practices in Bradford and due to receive their NHS bowel cancer screening invitation will be assigned to two groups: standard kit (usual screening kit only) and enhanced kit (culturally tailored instruction letter and biodegradable poo catcher). Uptake of bowel cancer screening among South Asian participants in each group will be assessed 13 weeks after the identification of the final participant. The findings of this study will provide valuable information for policy makers about how to address population specific barriers to bowel cancer screening using culturally tailored approaches in the UK.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
January 12, 2026
CompletedFirst Posted
Study publicly available on registry
January 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedJanuary 29, 2026
November 1, 2025
1.4 years
January 12, 2026
January 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Return of bowel screening kit for testing
% of individuals who return their bowel screening kit for foecal immunochemical testing measured using data recorded in their clinical records
13 weeks (screening episode)
Secondary Outcomes (1)
Bowel cancer screening test result
13 weeks (screening episode)
Other Outcomes (3)
Practicality of implementation of the enhanced kit
13 weeks (screening episode)
Costs
13 weeks (screening episode)
Acceptability of implementation of enhanced kit
13 weeks (screening episode)
Study Arms (2)
Enhanced screening kit
EXPERIMENTALCulturally tailored enhanced screening kit, comprising an instruction letter and booklet, and a bio-degradable poo catcher
Usual kit
ACTIVE COMPARATORScreening kit only
Interventions
Home Fecal Occult Blood Test kit
Eligibility Criteria
You may qualify if:
- Patients registered with one of 17 participating GP practices in Bradford
- Patients invited for bowel cancer screening during the implementation period
You may not qualify if:
- \) Individuals who are self-referrals 2) Type 2 objectors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gateshead Health NHS Foundation Trustcollaborator
- Bradford Teaching Hospitals NHS Foundation Trustcollaborator
- University of Hulllead
Study Sites (1)
Northeast Bowel cancer Screening Hub
Gateshead, Yorkshire, United Kingdom
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 12, 2026
First Posted
January 29, 2026
Study Start
November 1, 2024
Primary Completion
April 1, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
January 29, 2026
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
Consent for sharing data has not been sought